Finally, a meta-analysis of studies reporting data on (DPP4-i) reveals that DPP4 inhibitors use was associated with reduced risk of PD: HR:0.69 95%CI:0.56–0.86 (92). This evidence concerns the gene DPP4 and Parkinson disease.